# So-Young International Inc.: financial statements, quarterly

SY · Nasdaq · CIK 1758530 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sy.md) · [Financials](/companies/sy/financials.md) · [Filings](/companies/sy/filings.md) · [Insiders](/companies/sy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sy/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [127](/filings/0001104659-20-051203.md) | [173](/filings/0001104659-21-058062.md) | [209](/filings/0001104659-22-054013.md) | [101](/filings/0001104659-23-049253.md) | [60.0](/filings/0001104659-24-051493.md) | [80.5](/filings/0001410578-25-000800.md) | [59.8](/filings/0001104659-26-047129.md) |
| Current assets | $m | [425](/filings/0001104659-20-051203.md) | [429](/filings/0001104659-21-058062.md) | [318](/filings/0001104659-22-054013.md) | [278](/filings/0001104659-23-049253.md) | [243](/filings/0001104659-24-051493.md) | [236](/filings/0001410578-25-000800.md) | [212](/filings/0001104659-26-047129.md) |
| Total assets | $m | [464](/filings/0001104659-20-051203.md) | [505](/filings/0001104659-21-058062.md) | [523](/filings/0001104659-22-054013.md) | [464](/filings/0001104659-23-049253.md) | [453](/filings/0001104659-24-051493.md) | [375](/filings/0001410578-25-000800.md) | [379](/filings/0001104659-26-047129.md) |
| Current liabilities | $m | [67.0](/filings/0001104659-20-051203.md) | [87.5](/filings/0001104659-21-058062.md) | [112](/filings/0001104659-22-054013.md) | [78.0](/filings/0001104659-23-049253.md) | [76.1](/filings/0001104659-24-051493.md) | [86.3](/filings/0001410578-25-000800.md) | [112](/filings/0001104659-26-047129.md) |
| Total liabilities | $m | [84.4](/filings/0001104659-20-051203.md) | [103](/filings/0001104659-21-058062.md) | [128](/filings/0001104659-22-054013.md) | [85.5](/filings/0001104659-23-049253.md) | [92.0](/filings/0001104659-24-051493.md) | [106](/filings/0001410578-25-000800.md) | [140](/filings/0001104659-26-047129.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | [4.2](/filings/0001104659-24-051493.md) | [9.6](/filings/0001410578-25-000800.md) | [5.7](/filings/0001104659-26-047129.md) |
| Shareholders' equity | $m | [380](/filings/0001104659-20-051203.md) | [398](/filings/0001104659-21-058062.md) | [384](/filings/0001104659-22-054013.md) | [362](/filings/0001104659-23-049253.md) | [344](/filings/0001104659-24-051493.md) | [252](/filings/0001410578-25-000800.md) | [222](/filings/0001104659-26-047129.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.